Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kavanagh, Simon
  • Heath, Emily
  • Hurren, Rose
  • Barghout, Samir H
  • Liyanage, Sanduni U
  • Siriwardena, Thirushi
  • Claudio, Jaime
  • Zhang, Tong
  • Sukhai, Mahadeo
  • Stockley, Tracy L
  • Kamel-Reid, Suzanne
  • Rostom, Amr
  • Khalaf, Dina
  • Lutynski, Andrzej
  • Rydlewski, Anna
  • Schuh, Andre C
  • Gupta, Vikas
  • Sibai, Hassan
  • Maze, Dawn
  • Chan, Steven M
  • Schimmer, Aaron D

publication date

  • December 7, 2017

published in